Encinitas, CA, United States of America

Wesley Kwan Mung Chong

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Nicox S.a., Agouron Pharmaceuticals, Inc.. Active years: 2003-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wesley Kwan Mung Chong. Retrieved from https://idiyas.com/inventor/wesley-kwan-mung-chong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0


 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2003-2012

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Wesley Kwan Mung Chong

Introduction: Wesley Kwan Mung Chong, an accomplished inventor based in Encinitas, CA, has made significant contributions to the field of pharmacology with five patents to his name. His work primarily focuses on the development of novel compounds aimed at treating ocular diseases, showcasing his dedication to improving patient well-being through innovation.

Latest Patents: Among his most recent patents, Chong has introduced groundbreaking advancements in ocular health. One notable patent involves nitric oxide donating prostamides, specifically nitroderivatives of prostaglandins that exhibit enhanced pharmacological activity and tolerability. These compounds hold promise for the treatment of glaucoma and ocular hypertension. Another significant invention is related to quinoxaline derivatives of alpha-2 adrenergic agonists, which are designed to improve pharmacological efficacy while providing better tolerability. These nitrooxyderivatives target ocular conditions, particularly those associated with high intraocular pressure and glaucoma.

Career Highlights: Chong's career has been marked by his association with reputable companies in the pharmaceutical sector. Notably, he has contributed his expertise to Nicox S.A. and Agouron Pharmaceuticals, Inc. His work in these organizations reflects his commitment to translating innovative research into practical medical solutions that address pressing health challenges.

Collaborations: Throughout his career, Chong has collaborated with esteemed colleagues, including Francesca Benedini and Stefano Biondi. These collaborative efforts have fostered an environment of creativity and shared knowledge, enhancing the potential for groundbreaking advancements in pharmacological treatments.

Conclusion: Wesley Kwan Mung Chong stands out as a notable figure in the realm of invention, with a focus on developing treatments for ocular diseases. His patents reflect a blend of innovation and practical application, underscoring the importance of scientific research in advancing healthcare. Through his work, Chong continues to inspire future generations of inventors and contribute to the ongoing evolution of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…